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Abstract
Background: Cystic fibrosis (CF) may strongly condition the life of affected people. CF may be associated with relevant
painful conditions caused by complications of the illness and also by therapy itself, which may represent an additional load of
suffering. This study was aimed at evaluating the prevalence of pain symptoms in adult CF patients, if they are noticed and
treated, and the influence of pain symptoms on patients’ life. Method: Using a questionnaire, we examined 239 adults with CF
(17% of the whole Italian adult CF population). Results: We found a high prevalence of painful episodes among CF adult
patients, as for both intensity and frequency. In a 2 months period 32.6% of patients experienced episodes of pain described as
intense to severe, and 29.7% had more than 10 occurrences of pain in the same location. Headache, gastric pain and backache
were the most frequently reported kind of pain. 59.8% of subjects perceived pain episodes as the cause of unfavorable effects on
their life. Only 42.6% of those with pain asked a CF center physician for help and another 3.5% a general practitioner.
Conclusion: Painful symptoms can be the cause of a worsening of the quality of life for adults with CF; the relevance of pain in
CF adult patients may often be underestimated; the assessment of pain should be routinely performed as a part of care in CF
centers.
 2003 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
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1. Introduction
Life expectancy of people with cystic fibrosis (CF)
has substantially increased over recent years. According
to a recent study the life expectancy of a baby with CF
born in 1990 is estimated at approximately 40 w1x. At
the present time, a large number of CF patients are
adults. In the United States, adults with CF represent
39.5% of the total and the predicted survival age is 33.4
years w2x. In Italy, approximately 38% of persons suf-
fering from CF are over 18 w3x.
The progressive deterioration in the health of patients
who survive into adult life may cause a decline of their
quality of life. In fact, because of their basic pulmonary
 The data resulting from this study were presented orally at the
16th North American CF Conference, New Orleans on October 3–6,
2002 and appeared in abstract form in the Conference proceedings
(Pediatric Pulmonology 2002; Supplement 24).
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disease, they may be restricted in their work and social
relations. Furthermore, the treatment necessary to keep
the disease from advancing usually takes up a great deal
of a CF adult’s life, it is generally quite invasive and
frequent hospitalizations are often necessary.
Besides these elements which negatively affect their
quality of life, patients with CF frequently develop
chronic complications due to their basic disease and,
with growing frequency, to the treatment they undergo.
In particular, among CF adults, there is a high prevalence
of problems such as, inter alia, osteoporosis w4x, hearing
loss due to treatment with antibiotics w5x, arthropathies
w6x, gastrooesophageal reflux w7x, fibrosing colonopathy
w8x, musculo-skeletal problems w9x, female urinary
incontinence w10x and vaginitis w11x. Many of these
complications are accompanied by more or less marked
pain symptoms, which go alongside other painful expe-
riences due to the acute complications possible in CF,
such as pneumothorax and dystal intestinal obstruction
52 F. Festini et al. / Journal of Cystic Fibrosis 3 (2004) 51–57
Table 1
Questions and possible answers in the administered questionnaire
Question Possible replies
1 In the past 2 months, have you experienced – Headache or pain in the frontal region
one or more of the following painful symptoms? – Cervical pain
– Pain in one or more joints
– Backache or lumbar pain
– Painful bones or muscular pain
– Pain in the stomach, heartburn
– Abdominal pain
– Chest pain
– Other types of pain not listed (please specify)
2 For each case in which the reply to question 1 Numeric rating scale 1 to 10:
was yes, what was the maximum intensity of (1 mild, 4 moderate, 7 strong, 10 severe)
pain, on a rating scale of 1 to 10?
3 For each case in which the reply to question 1 – 1
was yes, how many painful episodes did you – from 2 to 5
experience during the time period considered? – from 6 to 10
– more than 10
4 What did you do to fight the pain? Only one – I consulted a doctor at the CF center.
reply is allowed. – I consulted my GP.
– I consulted relations and friends.
– I made my own decision on how to fight the pain.
– I did nothing to fight the pain.
5 If you adopted any remedies, what were they? – I took drugs.
One or more replies are allowed. – I took homeopathic products.
– I adopted non-pharmacological remedies.
(please describe)
6 If in question 1 you reported experiencing pain, – I felt restricted in carrying out my normal
did the pain give rise to one or more of the everyday activities.
following negative consequences? – I was unable to carry out my normal everyday
activities.
– I lost days at work, school or studying.
– I suffered from sleeping disorders.
– I did not keep to the prescribed treatment.
syndrome (DIOS), and the numerous invasive practices
suffered by patients as, for example, frequent venipunc-
tures for the administration of antibiotics.
In clinical practice, nurses at Italian CF centers
noticed that an increasing number of adult CF patients
complained of pain. This made us realize that the
problem of pain in adult CF patients was worth assess-
ment from an epidemiological point of view, with
particular regard to the consequences it had on the
patients’ quality of life.
Until now, pain in CF adults has received little
attention in literature, since only a few authors have
studied the relevance of pain in CF. Some have dealt
with pain in the terminal stages of CF, and have included
children and adolescents in their studies w12x. So far
only a few, limited data are available on the prevalence
of the problem outside the terminal stages of the disease
and on its consequences on patients’ everyday life. In
particular, the problem of pain in CF adults has received
only limited attention, and has been analyzed only in
very small groups w13–15x.
The objectives of our study were:
To evaluate the prevalence of pain symptoms in adults
with CF.
To evaluate if and to what extent pain in CF patients is
detected and treated.
To evaluate the impact of pain on the daily life of CF
adults.
2. Materials, subjects and methods
The study was devised and conducted by the Italian
Group of Cystic Fibrosis Nurses. It commenced in
March 2001 and ended in June 2001.
To collect data we used a standard questionnaire
setting out six questions aimed at discovering the loca-
tion of painful symptoms, their frequency and intensity,
how they are treated and their effects on every day life.
Table 1 illustrates the questions on the questionnaire.
The questions put to patients referred to pain experi-
enced in the 2 months prior to completion of the
questionnaire.
The questionnaire was administered to people affected
by CF aged 18 or more who were followed in one of
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Table 2
Absolute frequencies (n), percentages (%) and 95% confidence inter-
vals of percentages (95% CI), of the different locations and types of
pain reported; Absolute frequencies, percentages and 95% confidence
intervals of percentages, of the highest intensity of pain experienced
by each patient; Absolute frequencies, percentages and 95% confi-
dence intervals of percentages, of frequencies of pain reported by each
patient in the 2-months period; Percentages are calculated on the total
of the examined group
n % 95% CI
Locationytype of reported pain
Headache or pain in the frontal region 151 63.1 56.9–69.0
Pain in the stomach, heartburn 123 51.4 45.1–57.7
Backache or lumbar pain 115 48.1 41.8–54.4
Painful bones or muscular pain 106 44.3 38.1–50.6
Pain in one or more joints 99 41.4 35.3–47.7
Abdominal pain 79 33.0 27.4–39.2
Chest pain 76 31.8 26.2–37.9
Cervical pain 68 28.4 23.1–34.4
Other types of pain not listed 14 5.8 3.5–9.5
Highest intensity of pain experienced by each patient
no pain 14 5.8 3.5–9.5
from 1 to 3 48 20.1 15.5–25.6
from 4 to 7 99 41.4 35.3–47.7
from 8 to 10 78 32.6 27.0–38.8
Frequency of pain episodes for each patient in the 2-month period
no pain 14 5.8 3.5–9.5
once 32 13.4 9.6–18.2
twice to five times 74 30.9 25.4–37.1
6 to 10 times 48 20.1 15.5–25.6
more than 10 times 71 29.7 24.2–35.7
the Italian CF centers. Subjects to be examined were
chosen randomly by each center participating in the
study, by drawing among all the adult patients who were
visited at the center in the study period. The proportion
of subjects drawn in each center was equal to the
proportion of CF adults followed by that center with
regard to the total number of Italian CF adults.
The questionnaires were administered during pro-
grammed routine visits to the center. A nurse of the CF
center obtained the patients’ consent and explained the
meaning of the questions. Each patient answered the
questionnaire with no limits of time and with the
possibility to ask the nurse for explanations about the
questions, if unclear. The nurse who administered the
questionnaire filled out a record with the following
clinical data of each patient: body mass index (BMI),
forced expiratory volume at 1 s (FEV1), the presence
of pancreatic insufficiency, the presence and the type of
chronic lung colonization by respiratory pathogens. All
24 Italian CF centers and CF units in which adult
patients were followed, were invited to participate.
The collected data were stored in a computerized
database and were processed with the Epi info 2002,
rev.1 program, by World Health Organization. Absolute
and relative frequencies of the observed variables were
calculated together with the 95% confidence intervals
(95% CI) of the relative frequencies.
3. Results
Fifteen Italian CF centers out of 24 participated to
the study. Two hundred and fifty adult CF patients were
invited to participate (128 females, 122 males). Two
hundred and thirty-nine CF patients accepted to answer
the questionnaire. On the basis of the data of the Italian
CF registry w3x they represent 17% of the whole Italian
adult CF population. Among those examined, 125 were
females (52.3%) and 114 males (47.7%). Mean age
was 26.1 years (median 25 years, range 18–43). Males’
mean age was 26.3 years (median 25 years—min. 18
max. 42). As for females, mean age was 25.78 years
(median 25 years, range 18–43)
3.1. Clinical conditions of the examined patients
Mean BMI of males was 20.97 ("2.88 S.D., median
20.84). Mean BMI of females was 19.93 ("2.39 S.D.,
median 19.94). Mean FEV1 was 56.71% of the predicted
("23.33 S.D., median 52%). 71.9% of patients had
pancreatic insufficiency. Chronic Pseudomonas aerugi-
nosa colonization of lungs was present in 71.9% of
patients, whereas 10.04% were chronically colonized by
Burkholderia Cepacia.
3.2. Prevalence of painful symptoms in CF adults
225 patients (94.1%, 95% CI:90.4–96.4) reported
they had episodes of pain during the previous 2 months.
3.3. Location and type of pain
Table 2 shows the type andyor the location of the
pain symptoms reported by CF adults in the considered
period, ordered from the most to the least reported.
Percentages are calculated on the total of the examined
group and are not reciprocally exclusive because many
patients reported the presence of more than one pain
symptom at the same time. Among the types or locations
of pain not listed in the questionnaire but reported by
patients as ‘Other’, the most reported were the pain
caused by oral and genital mycosis and by renal colics.
It is noticeable that 38.4% of subjects (ns92) report-
ed painful episodes in four or more different locations
over the 2-months period, and 16.8% (ns40) in three
locations at the same time.
37.2% of patients (ns89) reported they had both
headache and backache in the period and 34.7% (ns
83) reported both headache and gastric pain.
3.4. Intensity of pain
Table 2 shows the highest intensity of pain experi-
enced by each patient in the considered period. 10.8%
of CF adults (ns26, 95% CI:7.5–15.4%) rated 10 as
their most intense pain, that is ‘severe’.
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Table 3
Percentages (%) and 95% confidence intervals of percentages (95% CI), of severe pain and of pain more recurrent than 10 times in the period,
among the patients who complained for each type of pain. Percentages are calculated on the number of patients who complained for each type
of pain
Severe pain Pain which occurred )10 times
% 95% CI % 95% CI
Headache or pain in the frontal region 6.6 3.6–11.7 14.6 9.8–21.0
Backache or lumbar pain 8.7 4.7–15.2 17.4 11.5–25.3
Pain in the stomach, heartburn 2.4 0.8–6.9 14.6 9.4–21.9
Pain in one or more joints 4.0 1.5–9.9 18.1 11.8–26.9
Painful bones or muscular pain 3.7 1.4–9.3 11.3 6.6–18.7
Chest pain 2.6 0.7–9.1 13.3 7.3–22.5
Abdominal pain 2.5 0.7–8.7 11.4 6.1–20.2
Cervical pain 4.4 1.5–12.1 10.3 5.0–19.7
Other types of pain not listed 7.1 1.2–31.4 7.1 1.2–31.4
Table 4
Absolute frequencies (n), percentages (%) and 95% confidence intervals of percentages (95% CI), of negative consequences of pain on day-to-
day life, among patients who had pain. Percentages are not reciprocally exclusive
n % 95% CI
Restriction in carrying out normal everyday activities 90 40 33.8–46.5
Inability to carry out normal everyday activities 36 16 11.7–21.3
Lost of days at work, school or studying 50 22.2 17.2–28.1
Sleeping disorders 68 30.2 24.6–36.5
Failure to perform the prescribed treatments 25 11.1 7.6–15.8
3.5. Frequency of pain
Table 2 shows the frequencies of episodes of pain
reported by each patient for at least one type of pain in
the 2 previous months.
3.6. Prevalence of severe pain and of recurrent pain,
according to the location or type of pain
Table 3 shows, for each location or type of pain, the
percentages of severe pain (i.e. rated 10) and of pain
that occurred more than 10 times in the considered
period.
In our group of patients, backache is the type of pain
most frequently present in severe form, whereas joint
pain is the type of pain that occurs in the most recurrent
form.
3.7. What patients did to fight pain
Among the 225 patients who reported pain symptoms,
59 (26.2%, 95% CI:20.9–32.2) did nothing to fight the
pain. Fifteen patients (6.6%, 95% CI:4.1–10.7) decided
on their own what kind of measures to take and 47
(20.8%, 95% CI:16.1–26.6) consulted relatives and
friends. Ninety-six subjects (42.6%, 95% CI:36.3–49.2)
asked a CF center physician for help whereas 8 (3.5%,
95% CI:1.8–6.8) consulted their general practitioner.
3.8. Remedies adopted
Among the 166 patients who decided to fight pain,
152 (91.5%, 95% CI:86.3–94.9) took drugs, 3 (1.8%,
95% CI:0.6–5.1) took homeopathic products and 37
(22.2%, 95% CI:16.6–29.2) adopted non-pharmacolog-
ical remedies. Percentages are not reciprocally exclusive.
Among the non-pharmacological remedies adopted
patients reported massages, acupuncture, herbal reme-
dies, physical activity and rest.
3.9. Consequences of pain on daily life
Among the 225 patients who suffered from pain
episodes, 143 (63.5%, 95% CI:57.1–69.5) reported that
pain caused unfavorable effects on their day-to-day life.
Table 4 shows the negative consequences of pain on
daily life reported by patients. Since more answers were
possible, percentages are not reciprocally exclusive.
Patients who reported one or more negative effects of
pain on their daily life represent 59.8% of the whole
examined group of adults with CF.
4. Discussion
Our study examined for the first time the prevalence
of pain in a large group of adults suffering from CF. It
showed that in a group of Italian adults with CF,
representing one sixth of the entire adult CF population,
there is a high prevalence of pain, with regard to both
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intensity and frequency; almost one third of the patients
examined complained of pain described as strong to
severe, 11% reported severe pain. Almost one third of
patients complained of more than 10 episodes of the
same type of pain during the period considered.
There are many conditions and complications in CF
that may give rise to pain symptoms, even outside acute
situations like pneumothorax and pulmonary exacerba-
tions. Our study revealed that headache and gastric pain
are widespread among adults with CF. Backache is also
common and is the type of pain most frequently present
in severe form. Joint pain is the type of pain that occurs
in the most recurrent form.
Headache and frontal pain may accompany chronic
sinusitis and nasal polyps, which are frequent in CF
w16x. In more advanced stages of the disease, headache
may be the consequence of hypercarbia andyor hypoxia.
With regard to gastric pain, gastro-oesophageal reflux
is a frequently encountered complication in CF and it is
probable that the cause of some of the pain which our
patients defined as heartburn may be related to it.
With regard to backache, some papers report an
increased prevalence of excessive kyphosis in patients
with CF w9x as well as postural abnormalities and
vertebral wedging w17x, which could explain this
symptom.
CF related arthritis is a frequently described condition
in CF, which occurs with joint pains. When more serious
pulmonary conditions are involved, another form of
joint disease described in CF adults is the hypertrophic
pulmonary osteoarthropathy, which occurs with joint
pains and has an insidious onset w18x.
Osteoporosis occurs with increasing frequency in
patients with CF w4x and may be the cause of bone
pains and severe back pains.
DIOS and fibrosing colonopathy, which have also
been reported in adults with CF, are conditions associ-
ated with painful abdominal symptomatology in CF.
Among the possible causes of abdominal pain is also
Chron’s disease, whose incidence is 17 times higher in
persons with CF than in the general population w8x.
However, even the treatment of CF itself may be
cause of painful symptoms. The location and high
prevalence of some types of pain observed in our study
would appear to confirm this possibility. It has been
suggested that among the possible iatrogenic causes of
pain in CF adults respiratory physiotherapy may play a
role and is indicated as the possible origin of chest and
back pain w19x. Prolonged oxygen therapy may be the
cause of headache, following dryness and flogosis of
the paranasal sinuses. In addition, a high incidence of
antibiotic related genital candidosis has been reported
w11x. It is known that among drugs, the frequent use of
NSAIDs and cortisone drugs is the possible cause of
gastralgia, while the use of fluoroquinolones, which is
frequent in CF patients, has occasionally been associated
with the onset of arthralgia w20x. High doses of pancre-
atic enzymes have been correlated to the onset of
fibrosing colonopathy w8x. Even though transitory, the
pain caused by the administration of i.v. Pamidronate,
used in the treatment of osteoporosis, has been reported
w21x.
It must be emphasized that our study did not investi-
gate pain caused by the procedures to which CF adults
are subjected. For example, they undergo frequent veni-
punctures necessary for taking blood samples and
administering cycles of i.v. antibiotic treatment. These
and other invasive procedures are a considerable burden
for CF adults. Our questionnaire did not contemplate
procedural pain among the possible types of pain to
report. From this point of view, our work may well have
underestimated the overall weight of pain on these
patients.
Thanks to an extended survival rate, most CF sufferers
now survive into adult life and, like their peers, have to
face the problems of their school career, earning their
living, placement in the work environment and long-
term planning of their family and social life. In facing
their adult life commitments, the disease represents a
heavy burden for these people. In many circumstances,
it stops them from undertaking normal activities. Our
study has revealed that pain may represent a cause of
suffering and difficulty, which accompanies and adds to
those caused by their basic pathology. In fact, almost
60% of the CF adults we studied reported that the
painful symptomatology stopped or restricted their nor-
mal daily activities.
The negative effects of pain (as for example, sleeping
problems) reported by the patients regard not only their
social activities but also their individual well-being, and
may even have repercussions on their very state of
health, since they can be the cause of abandoning
treatment.
Chastain report that in a group of 31 CF adults, 64%
complained that pain interfered significantly with their
daily lives w14x. Bilton et al. reported a percentage of
63% in a sample of 66 adults w13x.
One particularly interesting fact emerging from our
study is that only just over half the patients complaining
of pain turned to their doctor for help. The paper by
Bilton, on the contrary, reports a higher figure w13x,
while Eksterowicz, although not supplying data,
acknowledges the possibility that pain in CF patients is
frequently underestimated w22x.
This goes hand in hand with another particularly
important fact, i.e. more than a quarter of CF adults,
did nothing to alleviate their pain and simply endured
it.
In our opinion, these two facts may imply that there
are potential difficulties and obstacles to effectively face
the problem of pain in CF adults. In this connection,
two considerations can be made. From the patient’s
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point of view, our data appear to suggest that CF adults
tend to endure their pain without reporting it.
If the data are considered from the point of view of
the caregivers’ responsibility, we can hypothesize that
there is a problem of caregivers recognizing and paying
attention to the patient’s pain, i.e. pain may be not
recorded or perceived as an aspect of the patient’s
clinical condition that influences his quality of life or
his clinical condition.
One of the effects we aim to produce with the results
of our study is to awaken caregivers of CF patients to
the importance of pain in these patients. The data we
have recorded draw attention to the necessity for a
routine evaluation of CF patients’ pain, making it an
integral part of periodic controls and clinical assessment.
Furthermore, they emphasize the need for caregivers to
set themselves the target of treating pain in adults so
that they can, as far as possible, relieve this burden on
their patients’ already difficult daily lives.
The relief of pain in CF patients must therefore be
approached from two directions: on the one side, pain
relieving treatment should aim at treating painful symp-
toms directly related to the basic pathology or to related
complications or clinical manifestations, the onset of
which is sometimes insidious and with a tendency to
become chronic. On the other, it should be directed at
reducing the painful effects of essential drugs and
treatment.
One of the obstacles to the pharmacological treatment
of pain in these patients is represented by the side effects
of some drugs, as for example, constipation caused by
opiates, which may favor the onset of DIOS. In some
patients, hepatic damage caused by the disease and renal
overload, to which many patients are subject due to the
high doses of antibiotics and drugs taken every day,
may be considered a limitation to the use of some pain-
killing drugs. In many painful conditions, non-pharma-
cological techniques, such as deep breathing, relaxation,
imagery, distraction, calming self-statements, heat, cold,
massage and exercise may be effective w23x.
The questionnaire used for our study probably lacked
the capacity to record some types of pain: it did not, in
fact, contemplate pain in the genital area or the oral
cavity. The patients themselves, however, indicated pain-
ful areas that were not envisaged, by using the open
option in one of the questions.
In conclusion, our study revealed a high prevalence
of pain in a large group of adults suffering from cystic
fibrosis. It also showed that pain negatively affects the
daily lives of over half the patients examined, often
quite significantly, and in such a way as to restrict their
daily activities. It also brought to light that in more than
half the cases CF patients do not report pain to their
caregivers and in a quarter of cases pain is simply
endured.
With the progressive increase of the average survival
age of CF patients, the problem of managing pain in
these patients is destined to assume increasing impor-
tance and should be carefully assessed and dealt with.
The assessment of pain should become a routine
procedure in CF clinical examination and attention to
pain-related problems should become an integral part of
care in CF centers.
A pain management specialist should be included on
the staff of CF centers or should be among the profes-
sionals to whom the center can refer on a routine basis.
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